These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2768794)

  • 1. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.
    Merkel C; Bolognesi M; Finucci GF; Angeli P; Caregaro L; Rondana M; Gatta A
    J Hepatol; 1989 Jul; 9(1):16-22. PubMed ID: 2768794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
    Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
    Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M; García-Pagán JC; Bosch J; Rodés J
    Med Clin (Barc); 1992 Feb; 98(8):290-4. PubMed ID: 1560714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML; Bendtsen F; Kallemose T; Møller S
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.
    Møller S; la Cour Sibbesen E; Madsen JL; Bendtsen F
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1093-1099. PubMed ID: 30221390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver.
    Gupta S; Chawla Y; Kaur J; Saxena R; Duseja A; Dhiman RK; Choudhary NS
    Trop Gastroenterol; 2012; 33(2):129-34. PubMed ID: 23025060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis.
    Barbare JC; Poupon RE; Jaillon P; Prod'homme S; Darnis F; Poupon RY
    J Hepatol; 1985; 1(3):253-9. PubMed ID: 4067257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis.
    Møller S; Henriksen JH; Sjöstedt S; Bendtsen F
    J Gastroenterol Hepatol; 2022 Apr; 37(4):692-699. PubMed ID: 35016257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
    Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
    Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis.
    Bolognesi M; Merkel C; Bianco S; Angeli P; Sacerdoti D; Amodio P; Gatta A
    Hepatology; 1994 Mar; 19(3):628-34. PubMed ID: 8119687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of one-year pretransplant survival in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Binder L; Pichlmayr R
    Hepatology; 1991 Dec; 14(6):1029-34. PubMed ID: 1959850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pretransplant prognosis in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Rodeck B; Duewel J; Schulz M; Schmidt FW; Brodehl J; Pichlmayr R
    Transplantation; 1991 Apr; 51(4):801-6. PubMed ID: 2014533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt.
    Pomier-Layrargues G; Huet PM; Infante-Rivard C; Villeneuve JP; Marleau D; Duguay L; Tanguay S; Lavoie P
    Hepatology; 1988; 8(6):1506-10. PubMed ID: 3192163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    Paternostro R; Reiberger T; Mandorfer M; Schwarzer R; Schwabl P; Bota S; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    J Gastroenterol Hepatol; 2017 Jan; 32(1):184-190. PubMed ID: 27164413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.